Thrive Earlier Detection’s eye-catching debut underscores the tantalizing reality that one of liquid biopsy’s most ambitious projects, a multi-cancer blood screening test, might be achievable, but even with the involvement of veteran scientists and executives, the start-up has a lot to prove.Read Article
Wendy writes on the medical devices and clinical diagnostics sectors, where she focuses on orthopedics/spine, molecular diagnostics and personalized medicine, clinical genomics, womens’ health/ femtech, and reimbursement/commercial strategy and innovation related to these specialties. She welcomes and encourages ideas and input from members of the MedTech Strategist Community.
Her career spans more than 20+ years as a top writer and manager focused on qualitative analysis of the global life sciences industry. She is Chair of Young Women in Bio Metro NY, an organization devoted to encouraging secondary students in the NY area to pursuit STEM careers and on the board of the Columbia Business School of Alumni Club NY